img

Global Medical Marijuana Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medical Marijuana Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Medical Marijuana market size was US$ 4000 million in 2024 and is forecast to a readjusted size of US$ 18060 million by 2034 with a CAGR of 23.8% during the forecast period 2024-2034.
The United States market for Medical Marijuana is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Medical Marijuana is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Medical Marijuana is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Medical Marijuana include Scotts Miracle-Gro, Canopy Growth, GW Pharmaceuticals, Aurora Cannabis, Aphria, MedReLeaf, Insys Therapeutics, Sprott and CanniMed Therapeutics, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Medical Marijuana, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Medical Marijuana by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Medical Marijuana market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Medical Marijuana market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Scotts Miracle-Gro
Canopy Growth
GW Pharmaceuticals
Aurora Cannabis
Aphria
MedReLeaf
Insys Therapeutics
Sprott
CanniMed Therapeutics
Horizons Marijuana Life Sciences Index ETF
By Type
Dried Flower
Oils + Concentrates
Softgel Capsules
By Application
Muscle Spasms
Nausea (from cancer chemotherapy)
Chronic Illness (HIV/Nerve Pain)
Seizure Disorders
Crohn's Disease
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Medical Marijuana in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Medical Marijuana manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Marijuana sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Medical Marijuana Definition
1.2 Market by Type
1.2.1 Global Medical Marijuana Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Dried Flower
1.2.3 Oils + Concentrates
1.2.4 Softgel Capsules
1.3 Market Segment by Application
1.3.1 Global Medical Marijuana Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Muscle Spasms
1.3.3 Nausea (from cancer chemotherapy)
1.3.4 Chronic Illness (HIV/Nerve Pain)
1.3.5 Seizure Disorders
1.3.6 Crohn's Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Medical Marijuana Sales
2.1 Global Medical Marijuana Revenue Estimates and Forecasts 2018-2034
2.2 Global Medical Marijuana Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Medical Marijuana Revenue by Region
2.3.1 Global Medical Marijuana Revenue by Region (2018-2023)
2.3.2 Global Medical Marijuana Revenue by Region (2024-2034)
2.4 Global Medical Marijuana Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Medical Marijuana Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Medical Marijuana Sales Quantity by Region
2.6.1 Global Medical Marijuana Sales Quantity by Region (2018-2023)
2.6.2 Global Medical Marijuana Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Medical Marijuana Sales Quantity by Manufacturers
3.1.1 Global Medical Marijuana Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Medical Marijuana Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Medical Marijuana Sales in 2024
3.2 Global Medical Marijuana Revenue by Manufacturers
3.2.1 Global Medical Marijuana Revenue by Manufacturers (2018-2023)
3.2.2 Global Medical Marijuana Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Medical Marijuana Revenue in 2024
3.3 Global Medical Marijuana Sales Price by Manufacturers
3.4 Global Key Players of Medical Marijuana, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Medical Marijuana Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Medical Marijuana, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Medical Marijuana, Product Offered and Application
3.8 Global Key Manufacturers of Medical Marijuana, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Medical Marijuana Sales Quantity by Type
4.1.1 Global Medical Marijuana Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Medical Marijuana Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Medical Marijuana Sales Quantity Market Share by Type (2018-2034)
4.2 Global Medical Marijuana Revenue by Type
4.2.1 Global Medical Marijuana Historical Revenue by Type (2018-2023)
4.2.2 Global Medical Marijuana Forecasted Revenue by Type (2024-2034)
4.2.3 Global Medical Marijuana Revenue Market Share by Type (2018-2034)
4.3 Global Medical Marijuana Price by Type
4.3.1 Global Medical Marijuana Price by Type (2018-2023)
4.3.2 Global Medical Marijuana Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Medical Marijuana Sales Quantity by Application
5.1.1 Global Medical Marijuana Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Medical Marijuana Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Medical Marijuana Sales Quantity Market Share by Application (2018-2034)
5.2 Global Medical Marijuana Revenue by Application
5.2.1 Global Medical Marijuana Historical Revenue by Application (2018-2023)
5.2.2 Global Medical Marijuana Forecasted Revenue by Application (2024-2034)
5.2.3 Global Medical Marijuana Revenue Market Share by Application (2018-2034)
5.3 Global Medical Marijuana Price by Application
5.3.1 Global Medical Marijuana Price by Application (2018-2023)
5.3.2 Global Medical Marijuana Price Forecast by Application (2024-2034)
6 North America
6.1 North America Medical Marijuana Sales by Company
6.1.1 North America Medical Marijuana Revenue by Company (2018-2023)
6.1.2 North America Medical Marijuana Sales Quantity by Company (2018-2023)
6.2 North America Medical Marijuana Market Size by Type
6.2.1 North America Medical Marijuana Sales Quantity by Type (2018-2034)
6.2.2 North America Medical Marijuana Revenue by Type (2018-2034)
6.3 North America Medical Marijuana Market Size by Application
6.3.1 North America Medical Marijuana Sales Quantity by Application (2018-2034)
6.3.2 North America Medical Marijuana Revenue by Application (2018-2034)
6.4 North America Medical Marijuana Market Size by Country
6.4.1 North America Medical Marijuana Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Medical Marijuana Revenue by Country (2018-2034)
6.4.3 North America Medical Marijuana Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Medical Marijuana Sales by Company
7.1.1 Europe Medical Marijuana Sales Quantity by Company (2018-2023)
7.1.2 Europe Medical Marijuana Revenue by Company (2018-2023)
7.2 Europe Medical Marijuana Market Size by Type
7.2.1 Europe Medical Marijuana Sales Quantity by Type (2018-2034)
7.2.2 Europe Medical Marijuana Revenue by Type (2018-2034)
7.3 Europe Medical Marijuana Market Size by Application
7.3.1 Europe Medical Marijuana Sales Quantity by Application (2018-2034)
7.3.2 Europe Medical Marijuana Revenue by Application (2018-2034)
7.4 Europe Medical Marijuana Market Size by Country
7.4.1 Europe Medical Marijuana Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Medical Marijuana Revenue by Country (2018-2034)
7.4.3 Europe Medical Marijuana Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Medical Marijuana Sales by Company
8.1.1 China Medical Marijuana Sales Quantity by Company (2018-2023)
8.1.2 China Medical Marijuana Revenue by Company (2018-2023)
8.2 China Medical Marijuana Market Size by Type
8.2.1 China Medical Marijuana Sales Quantity by Type (2018-2034)
8.2.2 China Medical Marijuana Revenue by Type (2018-2034)
8.3 China Medical Marijuana Market Size by Application
8.3.1 China Medical Marijuana Sales Quantity by Application (2018-2034)
8.3.2 China Medical Marijuana Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Medical Marijuana Sales by Company
9.1.1 APAC Medical Marijuana Sales Quantity by Company (2018-2023)
9.1.2 APAC Medical Marijuana Revenue by Company (2018-2023)
9.2 APAC Medical Marijuana Market Size by Type
9.2.1 APAC Medical Marijuana Sales Quantity by Type (2018-2034)
9.2.2 APAC Medical Marijuana Revenue by Type (2018-2034)
9.3 APAC Medical Marijuana Market Size by Application
9.3.1 APAC Medical Marijuana Sales Quantity by Application (2018-2034)
9.3.2 APAC Medical Marijuana Revenue by Application (2018-2034)
9.4 APAC Medical Marijuana Market Size by Region
9.4.1 APAC Medical Marijuana Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Medical Marijuana Revenue by Region (2018-2034)
9.4.3 APAC Medical Marijuana Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Medical Marijuana Sales by Company
10.1.1 Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Medical Marijuana Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Medical Marijuana Market Size by Type
10.2.1 Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Medical Marijuana Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Medical Marijuana Market Size by Application
10.3.1 Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Medical Marijuana Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Medical Marijuana Market Size by Country
10.4.1 Middle East, Africa and Latin America Medical Marijuana Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Medical Marijuana Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Scotts Miracle-Gro
11.1.1 Scotts Miracle-Gro Company Information
11.1.2 Scotts Miracle-Gro Overview
11.1.3 Scotts Miracle-Gro Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Scotts Miracle-Gro Medical Marijuana Products and Services
11.1.5 Scotts Miracle-Gro Medical Marijuana SWOT Analysis
11.1.6 Scotts Miracle-Gro Recent Developments
11.2 Canopy Growth
11.2.1 Canopy Growth Company Information
11.2.2 Canopy Growth Overview
11.2.3 Canopy Growth Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Canopy Growth Medical Marijuana Products and Services
11.2.5 Canopy Growth Medical Marijuana SWOT Analysis
11.2.6 Canopy Growth Recent Developments
11.3 GW Pharmaceuticals
11.3.1 GW Pharmaceuticals Company Information
11.3.2 GW Pharmaceuticals Overview
11.3.3 GW Pharmaceuticals Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 GW Pharmaceuticals Medical Marijuana Products and Services
11.3.5 GW Pharmaceuticals Medical Marijuana SWOT Analysis
11.3.6 GW Pharmaceuticals Recent Developments
11.4 Aurora Cannabis
11.4.1 Aurora Cannabis Company Information
11.4.2 Aurora Cannabis Overview
11.4.3 Aurora Cannabis Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Aurora Cannabis Medical Marijuana Products and Services
11.4.5 Aurora Cannabis Medical Marijuana SWOT Analysis
11.4.6 Aurora Cannabis Recent Developments
11.5 Aphria
11.5.1 Aphria Company Information
11.5.2 Aphria Overview
11.5.3 Aphria Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Aphria Medical Marijuana Products and Services
11.5.5 Aphria Medical Marijuana SWOT Analysis
11.5.6 Aphria Recent Developments
11.6 MedReLeaf
11.6.1 MedReLeaf Company Information
11.6.2 MedReLeaf Overview
11.6.3 MedReLeaf Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 MedReLeaf Medical Marijuana Products and Services
11.6.5 MedReLeaf Medical Marijuana SWOT Analysis
11.6.6 MedReLeaf Recent Developments
11.7 Insys Therapeutics
11.7.1 Insys Therapeutics Company Information
11.7.2 Insys Therapeutics Overview
11.7.3 Insys Therapeutics Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Insys Therapeutics Medical Marijuana Products and Services
11.7.5 Insys Therapeutics Medical Marijuana SWOT Analysis
11.7.6 Insys Therapeutics Recent Developments
11.8 Sprott
11.8.1 Sprott Company Information
11.8.2 Sprott Overview
11.8.3 Sprott Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Sprott Medical Marijuana Products and Services
11.8.5 Sprott Medical Marijuana SWOT Analysis
11.8.6 Sprott Recent Developments
11.9 CanniMed Therapeutics
11.9.1 CanniMed Therapeutics Company Information
11.9.2 CanniMed Therapeutics Overview
11.9.3 CanniMed Therapeutics Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 CanniMed Therapeutics Medical Marijuana Products and Services
11.9.5 CanniMed Therapeutics Medical Marijuana SWOT Analysis
11.9.6 CanniMed Therapeutics Recent Developments
11.10 Horizons Marijuana Life Sciences Index ETF
11.10.1 Horizons Marijuana Life Sciences Index ETF Company Information
11.10.2 Horizons Marijuana Life Sciences Index ETF Overview
11.10.3 Horizons Marijuana Life Sciences Index ETF Medical Marijuana Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Horizons Marijuana Life Sciences Index ETF Medical Marijuana Products and Services
11.10.5 Horizons Marijuana Life Sciences Index ETF Medical Marijuana SWOT Analysis
11.10.6 Horizons Marijuana Life Sciences Index ETF Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Medical Marijuana Value Chain Analysis
12.2 Medical Marijuana Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Medical Marijuana Production Mode & Process
12.4 Medical Marijuana Sales and Marketing
12.4.1 Medical Marijuana Sales Channels
12.4.2 Medical Marijuana Distributors
12.5 Medical Marijuana Customers
13 Market Dynamics
13.1 Medical Marijuana Industry Trends
13.2 Medical Marijuana Market Drivers
13.3 Medical Marijuana Market Challenges
13.4 Medical Marijuana Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Medical Marijuana Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Dried Flower
Table 3. Major Manufacturers of Oils + Concentrates
Table 4. Major Manufacturers of Softgel Capsules
Table 5. Global Medical Marijuana Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Medical Marijuana Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. Global Medical Marijuana Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Medical Marijuana Revenue Market Share by Region (2018-2023)
Table 9. Global Medical Marijuana Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global Medical Marijuana Revenue Market Share by Region (2024-2034)
Table 11. Global Medical Marijuana Sales Quantity by Region: 2018 VS 2024 VS 2034 (K MT)
Table 12. Global Medical Marijuana Sales by Region (2018-2023) & (K MT)
Table 13. Global Medical Marijuana Sales Market Share by Region (2018-2023)
Table 14. Global Medical Marijuana Sales by Region (2024-2034) & (K MT)
Table 15. Global Medical Marijuana Sales Market Share by Region (2024-2034)
Table 16. Global Medical Marijuana Sales Quantity by Manufacturers (2018-2023) & (K MT)
Table 17. Global Medical Marijuana Sales Quantity Share by Manufacturers (2018-2023)
Table 18. Global Medical Marijuana Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Medical Marijuana Revenue Share by Manufacturers (2018-2023)
Table 20. Global Medical Marijuana Price by Manufacturers 2018-2023 (USD/MT)
Table 21. Global Key Players of Medical Marijuana, Industry Ranking, 2021 VS 2024
Table 22. Global Medical Marijuana Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Medical Marijuana by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Marijuana as of 2024)
Table 24. Global Key Manufacturers of Medical Marijuana, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Medical Marijuana, Product Offered and Application
Table 26. Global Key Manufacturers of Medical Marijuana, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Medical Marijuana Sales Quantity by Type (2018-2023) & (K MT)
Table 29. Global Medical Marijuana Sales Quantity by Type (2024-2034) & (K MT)
Table 30. Global Medical Marijuana Sales Quantity Share by Type (2018-2023)
Table 31. Global Medical Marijuana Sales Quantity Share by Type (2024-2034)
Table 32. Global Medical Marijuana Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Medical Marijuana Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global Medical Marijuana Revenue Share by Type (2018-2023)
Table 35. Global Medical Marijuana Revenue Share by Type (2024-2034)
Table 36. Medical Marijuana Price by Type (2018-2023) & (USD/MT)
Table 37. Global Medical Marijuana Price Forecast by Type (2024-2034) & (USD/MT)
Table 38. Global Medical Marijuana Sales Quantity by Application (2018-2023) & (K MT)
Table 39. Global Medical Marijuana Sales Quantity by Application (2024-2034) & (K MT)
Table 40. Global Medical Marijuana Sales Quantity Share by Application (2018-2023)
Table 41. Global Medical Marijuana Sales Quantity Share by Application (2024-2034)
Table 42. Global Medical Marijuana Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Medical Marijuana Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global Medical Marijuana Revenue Share by Application (2018-2023)
Table 45. Global Medical Marijuana Revenue Share by Application (2024-2034)
Table 46. Medical Marijuana Price by Application (2018-2023) & (USD/MT)
Table 47. Global Medical Marijuana Price Forecast by Application (2024-2034) & (USD/MT)
Table 48. North America Medical Marijuana Revenue by Company (2018-2023) & (US$ Million)
Table 49. North America Medical Marijuana Sales Quantity by Company (2018-2023) & (K MT)
Table 50. North America Medical Marijuana Sales Quantity by Type (2018-2023) & (K MT)
Table 51. North America Medical Marijuana Sales Quantity by Type (2024-2034) & (K MT)
Table 52. North America Medical Marijuana Revenue by Type (2018-2023) & (US$ Million)
Table 53. North America Medical Marijuana Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America Medical Marijuana Sales Quantity by Application (2018-2023) & (K MT)
Table 55. North America Medical Marijuana Sales Quantity by Application (2024-2034) & (K MT)
Table 56. North America Medical Marijuana Revenue by Application (2018-2023) & (US$ Million)
Table 57. North America Medical Marijuana Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America Medical Marijuana Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 59. North America Medical Marijuana Revenue by Country (2018-2023) & (US$ Million)
Table 60. North America Medical Marijuana Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America Medical Marijuana Sales Quantity by Country (2018-2023) & (K MT)
Table 62. North America Medical Marijuana Sales Quantity by Country (2024-2034) & (K MT)
Table 63. Europe Medical Marijuana Sales Quantity by Company (2018-2023) & (K MT)
Table 64. Europe Medical Marijuana Revenue by Company (2018-2023) & (US$ Million)
Table 65. Europe Medical Marijuana Sales Quantity by Type (2018-2023) & (K MT)
Table 66. Europe Medical Marijuana Sales Quantity by Type (2024-2034) & (K MT)
Table 67. Europe Medical Marijuana Revenue by Type (2018-2023) & (US$ Million)
Table 68. Europe Medical Marijuana Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe Medical Marijuana Sales Quantity by Application (2018-2023) & (K MT)
Table 70. Europe Medical Marijuana Sales Quantity by Application (2024-2034) & (K MT)
Table 71. Europe Medical Marijuana Revenue by Application (2018-2023) & (US$ Million)
Table 72. Europe Medical Marijuana Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe Medical Marijuana Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 74. Europe Medical Marijuana Revenue by Country (2018-2023) & (US$ Million)
Table 75. Europe Medical Marijuana Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe Medical Marijuana Sales Quantity by Country (2018-2023) & (K MT)
Table 77. Europe Medical Marijuana Sales Quantity by Country (2024-2034) & (K MT)
Table 78. China Medical Marijuana Sales Quantity by Company (2018-2023) & (K MT)
Table 79. China Medical Marijuana Revenue by Company (2018-2023) & (US$ Million)
Table 80. China Medical Marijuana Sales Quantity by Type (2018-2023) & (K MT)
Table 81. China Medical Marijuana Sales Quantity by Type (2024-2034) & (K MT)
Table 82. China Medical Marijuana Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Medical Marijuana Revenue by Type (2024-2034) & (US$ Million)
Table 84. China Medical Marijuana Sales Quantity by Application (2018-2023) & (K MT)
Table 85. China Medical Marijuana Sales Quantity by Application (2024-2034) & (K MT)
Table 86. China Medical Marijuana Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Medical Marijuana Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC Medical Marijuana Sales Quantity by Company (2018-2023) & (K MT)
Table 89. APAC Medical Marijuana Revenue by Company (2018-2023) & (US$ Million)
Table 90. APAC Medical Marijuana Sales Quantity by Type (2018-2023) & (K MT)
Table 91. APAC Medical Marijuana Sales Quantity by Type (2024-2034) & (K MT)
Table 92. APAC Medical Marijuana Revenue by Type (2018-2023) & (US$ Million)
Table 93. APAC Medical Marijuana Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC Medical Marijuana Sales Quantity by Application (2018-2023) & (K MT)
Table 95. APAC Medical Marijuana Sales Quantity by Application (2024-2034) & (K MT)
Table 96. APAC Medical Marijuana Revenue by Application (2018-2023) & (US$ Million)
Table 97. APAC Medical Marijuana Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC Medical Marijuana Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 99. APAC Medical Marijuana Revenue by Region (2018-2023) & (US$ Million)
Table 100. APAC Medical Marijuana Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC Medical Marijuana Sales Quantity by Region (2018-2023) & (K MT)
Table 102. APAC Medical Marijuana Sales Quantity by Region (2024-2034) & (K MT)
Table 103. Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Company (2018-2023) & (K MT)
Table 104. Middle East, Africa and Latin America Medical Marijuana Revenue by Company (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Type (2018-2023) & (K MT)
Table 106. Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Type (2024-2034) & (K MT)
Table 107. Middle East, Africa and Latin America Medical Marijuana Revenue by Type (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Medical Marijuana Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Application (2018-2023) & (K MT)
Table 110. Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Application (2024-2034) & (K MT)
Table 111. Middle East, Africa and Latin America Medical Marijuana Revenue by Application (2018-2023) & (US$ Million)
Table 112. Middle East, Africa and Latin America Medical Marijuana Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America Medical Marijuana Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America Medical Marijuana Revenue by Country (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Medical Marijuana Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Country (2018-2023) & (K MT)
Table 117. Middle East, Africa and Latin America Medical Marijuana Sales Quantity by Country (2024-2034) & (K MT)
Table 118. Scotts Miracle-Gro Company Information
Table 119. Scotts Miracle-Gro Description and Overview
Table 120. Scotts Miracle-Gro Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 121. Scotts Miracle-Gro Medical Marijuana Product and Services
Table 122. Scotts Miracle-Gro Medical Marijuana SWOT Analysis
Table 123. Scotts Miracle-Gro Recent Developments
Table 124. Canopy Growth Company Information
Table 125. Canopy Growth Description and Overview
Table 126. Canopy Growth Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 127. Canopy Growth Medical Marijuana Product and Services
Table 128. Canopy Growth Medical Marijuana SWOT Analysis
Table 129. Canopy Growth Recent Developments
Table 130. GW Pharmaceuticals Company Information
Table 131. GW Pharmaceuticals Description and Overview
Table 132. GW Pharmaceuticals Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 133. GW Pharmaceuticals Medical Marijuana Product and Services
Table 134. GW Pharmaceuticals Medical Marijuana SWOT Analysis
Table 135. GW Pharmaceuticals Recent Developments
Table 136. Aurora Cannabis Company Information
Table 137. Aurora Cannabis Description and Overview
Table 138. Aurora Cannabis Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 139. Aurora Cannabis Medical Marijuana Product and Services
Table 140. Aurora Cannabis Medical Marijuana SWOT Analysis
Table 141. Aurora Cannabis Recent Developments
Table 142. Aphria Company Information
Table 143. Aphria Description and Overview
Table 144. Aphria Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 145. Aphria Medical Marijuana Product and Services
Table 146. Aphria Medical Marijuana SWOT Analysis
Table 147. Aphria Recent Developments
Table 148. MedReLeaf Company Information
Table 149. MedReLeaf Description and Overview
Table 150. MedReLeaf Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 151. MedReLeaf Medical Marijuana Product and Services
Table 152. MedReLeaf Medical Marijuana SWOT Analysis
Table 153. MedReLeaf Recent Developments
Table 154. Insys Therapeutics Company Information
Table 155. Insys Therapeutics Description and Overview
Table 156. Insys Therapeutics Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 157. Insys Therapeutics Medical Marijuana Product and Services
Table 158. Insys Therapeutics Medical Marijuana SWOT Analysis
Table 159. Insys Therapeutics Recent Developments
Table 160. Sprott Company Information
Table 161. Sprott Description and Overview
Table 162. Sprott Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 163. Sprott Medical Marijuana Product and Services
Table 164. Sprott Medical Marijuana SWOT Analysis
Table 165. Sprott Recent Developments
Table 166. CanniMed Therapeutics Company Information
Table 167. CanniMed Therapeutics Description and Overview
Table 168. CanniMed Therapeutics Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 169. CanniMed Therapeutics Medical Marijuana Product and Services
Table 170. CanniMed Therapeutics Medical Marijuana SWOT Analysis
Table 171. CanniMed Therapeutics Recent Developments
Table 172. Horizons Marijuana Life Sciences Index ETF Company Information
Table 173. Horizons Marijuana Life Sciences Index ETF Description and Overview
Table 174. Horizons Marijuana Life Sciences Index ETF Medical Marijuana Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 175. Horizons Marijuana Life Sciences Index ETF Medical Marijuana Product and Services
Table 176. Horizons Marijuana Life Sciences Index ETF Medical Marijuana SWOT Analysis
Table 177. Horizons Marijuana Life Sciences Index ETF Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. Medical Marijuana Distributors List
Table 181. Medical Marijuana Customers List
Table 182. Medical Marijuana Market Trends
Table 183. Medical Marijuana Market Drivers
Table 184. Medical Marijuana Market Challenges
Table 185. Medical Marijuana Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Marijuana Product Picture
Figure 2. Global Medical Marijuana Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Medical Marijuana Market Share by Type in 2024 & 2034
Figure 4. Dried Flower Product Picture
Figure 5. Oils + Concentrates Product Picture
Figure 6. Softgel Capsules Product Picture
Figure 7. Global Medical Marijuana Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 8. Global Medical Marijuana Market Share by Application in 2024 & 2034
Figure 9. Muscle Spasms
Figure 10. Nausea (from cancer chemotherapy)
Figure 11. Chronic Illness (HIV/Nerve Pain)
Figure 12. Seizure Disorders
Figure 13. Crohn's Disease
Figure 14. Medical Marijuana Report Years Considered
Figure 15. Global Medical Marijuana Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Medical Marijuana Revenue 2018-2034 (US$ Million)
Figure 17. Global Medical Marijuana Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Medical Marijuana Sales Quantity 2018-2034 (K MT)
Figure 19. Global Medical Marijuana Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Medical Marijuana Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Medical Marijuana Sales Quantity YoY (2018-2034) & (K MT)
Figure 22. North America Medical Marijuana Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Medical Marijuana Sales Quantity YoY (2018-2034) & (K MT)
Figure 24. Europe Medical Marijuana Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Medical Marijuana Sales Quantity YoY (2018-2034) & (K MT)
Figure 26. China Medical Marijuana Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Medical Marijuana Sales Quantity YoY (2018-2034) & (K MT)
Figure 28. APAC Medical Marijuana Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Medical Marijuana Sales Quantity YoY (2018-2034) & (K MT)
Figure 30. Middle East, Africa and Latin America Medical Marijuana Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Medical Marijuana Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Medical Marijuana Revenue in 2024
Figure 33. Medical Marijuana Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Medical Marijuana Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Medical Marijuana Revenue Market Share by Type (2018-2034)
Figure 36. Global Medical Marijuana Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Medical Marijuana Revenue Market Share by Application (2018-2034)
Figure 38. North America Medical Marijuana Revenue Market Share by Company in 2024
Figure 39. North America Medical Marijuana Sales Quantity Market Share by Company in 2024
Figure 40. North America Medical Marijuana Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Medical Marijuana Revenue Market Share by Type (2018-2034)
Figure 42. North America Medical Marijuana Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Medical Marijuana Revenue Market Share by Application (2018-2034)
Figure 44. North America Medical Marijuana Revenue Share by Country (2018-2034)
Figure 45. North America Medical Marijuana Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Medical Marijuana Sales Quantity Market Share by Company in 2024
Figure 49. Europe Medical Marijuana Revenue Market Share by Company in 2024
Figure 50. Europe Medical Marijuana Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Medical Marijuana Revenue Market Share by Type (2018-2034)
Figure 52. Europe Medical Marijuana Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Medical Marijuana Revenue Market Share by Application (2018-2034)
Figure 54. Europe Medical Marijuana Revenue Share by Country (2018-2034)
Figure 55. Europe Medical Marijuana Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 57. France Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 61. China Medical Marijuana Sales Quantity Market Share by Company in 2024
Figure 62. China Medical Marijuana Revenue Market Share by Company in 2024
Figure 63. China Medical Marijuana Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Medical Marijuana Revenue Market Share by Type (2018-2034)
Figure 65. China Medical Marijuana Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Medical Marijuana Revenue Market Share by Application (2018-2034)
Figure 67. APAC Medical Marijuana Sales Quantity Market Share by Company in 2024
Figure 68. APAC Medical Marijuana Revenue Market Share by Company in 2024
Figure 69. APAC Medical Marijuana Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Medical Marijuana Revenue Market Share by Type (2018-2034)
Figure 71. APAC Medical Marijuana Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Medical Marijuana Revenue Market Share by Application (2018-2034)
Figure 73. APAC Medical Marijuana Revenue Share by Region (2018-2034)
Figure 74. APAC Medical Marijuana Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 79. India Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Medical Marijuana Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Medical Marijuana Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Medical Marijuana Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Medical Marijuana Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Medical Marijuana Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Medical Marijuana Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Medical Marijuana Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Medical Marijuana Revenue Share by Country (2018-2034)
Figure 88. Brazil Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Medical Marijuana Revenue (2018-2034) & (US$ Million)
Figure 93. Medical Marijuana Value Chain
Figure 94. Medical Marijuana Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed